121 related articles for article (PubMed ID: 22843473)
1. Central nervous system B-cell lymphoma in multiple sclerosis.
Lyons M; Patel N; Birch B; Boucher O
Turk Neurosurg; 2012; 22(4):493-5. PubMed ID: 22843473
[TBL] [Abstract][Full Text] [Related]
2. Concurrent occurrence of multiple sclerosis and primary CNS lymphoma: a case report.
Burgetova A; Seidl Z; Vaneckova M; Jakoubkova M
Neuro Endocrinol Lett; 2008 Dec; 29(6):867-70. PubMed ID: 19112415
[TBL] [Abstract][Full Text] [Related]
3. The development of primary central nervous system B-cell lymphoma in multiple sclerosis.
Lyons MK; Boucher OK; Birch BD; Patel NP
Neurohospitalist; 2011 Jul; 1(3):133-6. PubMed ID: 23983847
[TBL] [Abstract][Full Text] [Related]
4. Hypersexual sensations and behavior in a multiple sclerosis exacerbation: a case report.
Yang CC; Severson B; Bowen JD
Int J Impot Res; 2004 Aug; 16(4):382-4. PubMed ID: 15014553
[No Abstract] [Full Text] [Related]
5. [Therapy of multiple sclerosis].
Simó M
Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
[TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphoma in a patient treated with natalizumab.
Schweikert A; Kremer M; Ringel F; Liebig T; Duyster J; Stüve O; Hemmer B; Berthele A
Ann Neurol; 2009 Sep; 66(3):403-6. PubMed ID: 19798640
[TBL] [Abstract][Full Text] [Related]
7. Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance.
Blair NF; Brew BJ; Halpern JP
Neurology; 2012 Feb; 78(7):507-8. PubMed ID: 22302545
[No Abstract] [Full Text] [Related]
8. [Relapsing-remitting inflammatory disease of the central nervous system with normal MRI: multiple sclerosis or phenocopy in a series of 15 patients].
Lebrun C; Bourg V; Chanalet S; Chatel M
Rev Neurol (Paris); 2003 Apr; 159(4):397-404. PubMed ID: 12773868
[TBL] [Abstract][Full Text] [Related]
9. CNS lymphoma masquerading as hemorrhagic stroke.
Streletz LJ; Terzic D; Salem K; Raza A; Deleu DT
Clin Neurol Neurosurg; 2012 Apr; 114(3):262-4. PubMed ID: 22047650
[No Abstract] [Full Text] [Related]
10. Sporadic CJD in a patient with relaplsing-remitting multiple sclerosis on an immunomodulatory treatment.
Gabelić T; Habek M; Zerr I; Gawinecka J; Pavlisa G; Brinar VV
Acta Neurol Belg; 2011 Sep; 111(3):232-6. PubMed ID: 22141291
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Lanzillo R; Orefice G; Quarantelli M; Rinaldi C; Prinster A; Ventrella G; Spitaleri D; Lus G; Vacca G; Carotenuto B; Salvatore E; Brunetti A; Tedeschi G; Brescia Morra V
Mult Scler; 2010 Apr; 16(4):450-4. PubMed ID: 20150398
[TBL] [Abstract][Full Text] [Related]
12. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
[TBL] [Abstract][Full Text] [Related]
13. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma causing multiple spinal cord compression and carcinomatous meningitis in a 6-year-old: a case report.
Quadri SA; Sobani ZA; Enam SA; Enam K; Ashraf MS
J Pediatr Hematol Oncol; 2011 May; 33(4):312-5. PubMed ID: 21464767
[TBL] [Abstract][Full Text] [Related]
15. Cervical disk pathology in patients with multiple sclerosis: two case reports.
Mullen AE; Wilmarth MA; Lowe S
Phys Ther; 2012 Aug; 92(8):1055-64. PubMed ID: 22517783
[TBL] [Abstract][Full Text] [Related]
16. Long time interval between multiple sclerosis onset and occurrence of primary Sjögren's syndrome in a woman treated with interferon-beta.
De Santi L; Costantini MC; Annunziata P
Acta Neurol Scand; 2005 Sep; 112(3):194-6. PubMed ID: 16097964
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis preceding CNS lymphoma: a case report.
Yang JH; Wu SL
Acta Neurol Taiwan; 2007 Jun; 16(2):92-7. PubMed ID: 17685133
[TBL] [Abstract][Full Text] [Related]
18. Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.
Gonsette RE; Sindic C; D'hooghe MB; De Deyn PP; Medaer R; Michotte A; Seeldrayers P; Guillaume D;
Mult Scler; 2010 Apr; 16(4):455-62. PubMed ID: 20200198
[TBL] [Abstract][Full Text] [Related]
19. 3-methylcrotonyl-CoA carboxylase deficiency and severe multiple sclerosis.
Darin N; Andersen O; Wiklund LM; Holmgren D; Holme E
Pediatr Neurol; 2007 Feb; 36(2):132-4. PubMed ID: 17275669
[TBL] [Abstract][Full Text] [Related]
20. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
Lindquist S; Hassinger S; Lindquist JA; Sailer M
Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
